12 Health Care Stocks Moving In Friday's After-Market Session

Gainers

• CVRx CVRX shares rose 11.6% to $7.2 during Friday's after-market session. The market value of their outstanding shares is at $156.2 million.
• Abeona Therapeutics ABEO shares increased by 11.5% to $0.32. Trading volume for this security closed at 91.2K, accounting for 2.4% of its average full-day volume over the last 100 days. The company's market cap stands at $46.1 million.
• Jaguar Health JAGX stock moved upwards by 7.69% to $0.42. Trading volume for this security closed at 96.5K, accounting for 2.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $22.5 million.
• Kaleido Biosciences KLDO shares moved upwards by 7.35% to $1.46. The company's market cap stands at $62.1 million.
• Reshape Lifesciences RSLS stock rose 7.12% to $0.96. The company's market cap stands at $3.3 million.
• DarioHealth DRIO stock rose 6.65% to $6.89. The company's market cap stands at $149.0 million.

Losers

• Longeveron LGVN shares declined by 6.9% to $6.24 during Friday's after-market session. Longeveron's trading volume hit 161.4K shares by close, accounting for 12.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $130.1 million. As per the press release, Q4 earnings came out today.
• CohBar CWBR stock declined by 6.65% to $0.25. The company's market cap stands at $21.5 million.
• Ontrak OTRKP stock declined by 5.67% to $5.0.
• Kala Pharmaceuticals KALA shares decreased by 5.33% to $1.6. Trading volume for this security closed at 167.1K, accounting for 10.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $115.7 million.
• ENDRA Life Sciences NDRA stock fell 5.01% to $0.42. The company's market cap stands at $17.6 million.
• Olema Pharmaceuticals OLMA shares fell 4.99% to $4.19. The company's market cap stands at $169.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.